Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
20 hedge funds and large institutions have $1.09M invested in Guardion Health Sciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
5% less funds holding
Funds holding: 21 → 20 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
32% less capital invested
Capital invested by funds: $1.61M → $1.09M (-$524K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$803K |
| 2 |
Jane Street
New York
|
+$34.8K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$22.9K |
| 4 |
VF
Virtu Financial
New York
|
+$22.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$22.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$31K |
| 2 |
Morgan Stanley
New York
|
-$24.1K |
| 3 |
Two Sigma Advisers
New York
|
-$17K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$8K |
| 5 |
BlackRock
New York
|
-$1.08K |
GHSI Hedge Fund Activity: Q1 2022 in Review
20 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q1 2022, worth a combined $1.09M — down 32% from $1.61M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of GHSI and 4 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $803K. The largest seller was Millennium Management, exiting entirely with an estimated $31K sold.
- 20 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q1 2022, down from 21 in Q4 2021.
- Funds reported $1.09M of Guardion Health Sciences, Inc. Common Stock stock for Q1 2022, down 32% quarter-over-quarter.
- 4 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q1 2022 and 5 closed out, a net change of -1 holder.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q1 2022 was Renaissance Technologies, an estimated $803K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q1 2022 was Millennium Management, an estimated $31K sold.
Based on aggregated 13F filings for Q1 2022.